A. Huntsman-Labed

Pharmacokinetics and Exposure–Response of Vosoritide in Children with Achondroplasia

K. Larimore, M. Irving, J. Hoover-Fong, 2021, Clinical Pharmacokinetics.

SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia

J. Charrow, M. Irving, K. White, 2020, Journal of the Endocrine Society.

Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial

J. Charrow, M. Irving, K. White, 2020, The Lancet.

Phase IIB trial of oral Midostaurin (PKC412), the FMS-like tyrosine kinase 3 receptor (FLT3) and multi-targeted kinase inhibitor, in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome with either wild-type or mutated FLT3.

E. Estey, D. Gilliland, D. Gilliland, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.

J. Charrow, M. Irving, K. White, 2022, Genetics in medicine : official journal of the American College of Medical Genetics.

Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

J. Charrow, M. Irving, K. White, 2021, Genetics in Medicine.

Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia

C. Schiffer, H. Kantarjian, J. Cortes, 2012, Leukemia.

Determining the most appropriate components for a composite clinical trial outcome.

R. Califf, R. Holman, J. McMurray, 2008, American heart journal.

Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers

Robert Harrell, J. Morganroth, Yanfeng Wang, 2012, Cancer Chemotherapy and Pharmacology.

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population

S. Haffner, P. Deedwania, P. Diem, 2009, Diabetic medicine : a journal of the British Diabetic Association.